TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 156 filers reported holding TRAVERE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $30,061,363 | -13.8% | 1,957,120 | +26.2% | 0.04% | -18.2% |
| Q1 2023 | $34,870,790 | +298476.8% | 1,550,502 | +179.2% | 0.04% | +158.8% |
| Q4 2022 | $11,679 | -99.9% | 555,366 | +34.6% | 0.02% | +13.3% |
| Q3 2022 | $10,164,000 | +18.8% | 412,511 | +16.9% | 0.02% | +25.0% |
| Q2 2022 | $8,554,000 | +6.2% | 353,025 | +13.0% | 0.01% | +33.3% |
| Q1 2022 | $8,054,000 | -21.7% | 312,546 | -5.7% | 0.01% | -10.0% |
| Q4 2021 | $10,292,000 | +19.8% | 331,588 | -6.4% | 0.01% | +11.1% |
| Q3 2021 | $8,588,000 | – | 354,163 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,084,300 | $15,820,000 | 3.32% |
| ARMISTICE CAPITAL, LLC | 5,748,000 | $83,863,000 | 1.50% |
| RA Capital Management | 5,614,428 | $81,915,000 | 1.32% |
| Krensavage Asset Management, LLC | 140,000 | $2,043,000 | 0.69% |
| CM Management, LLC | 60,000 | $875,000 | 0.63% |
| Altium Capital Management LP | 170,484 | $2,487,000 | 0.58% |
| HighVista Strategies LLC | 53,498 | $781,000 | 0.55% |
| Sio Capital Management, LLC | 150,000 | $2,189,000 | 0.54% |
| MANGROVE PARTNERS IM, LLC | 295,037 | $4,305,000 | 0.44% |
| Rock Springs Capital Management LP | 1,494,164 | $21,800,000 | 0.43% |